Search results for "PATHOPHYSIOLOGY"

showing 10 items of 351 documents

Segmental dyskinesia in Wolff–Parkinson–White syndrome: A possible cause of dilatative cardiomyopathy

2006

Wolff-Parkinson-White (WPW) is a syndrome characterized by the presence of an accessory pathway that skipping A-V node may lead the electrical stimulus from the atrium directly to the ventricle. Some studies reported the finding of myocardial dyskinesia in the segments precociously activated by the accessory pathway, at echocardiogram and at nuclear cardiac study. Soria et al. reported, in 1985, an increased incidence of dilative cardiomyopathy in patients with WPW. The pathophysiological pathway that leads to ventricular dilation may be due to the increase of end-diastolic pressure secondary to a tachycardia-induced cardiomyopathy. Tachycardia-induced cardiomyopathy is usually secondary to…

Cardiomyopathy DilatedTachycardiamedicine.medical_specialtyCardiomyopathyHemodynamicsAccessory pathwayAneurysmInternal medicinemedicineHumanscardiovascular diseasesChildbusiness.industryInfantArrhythmias Cardiacmedicine.diseasePathophysiologymedicine.anatomical_structureDyskinesiaVentriclecardiovascular systemCardiologyWolff-Parkinson-White Syndromemedicine.symptomCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesInternational Journal of Cardiology
researchProduct

Hsp60 is actively secreted by human tumor cells

2010

Background Hsp60, a Group I mitochondrial chaperonin, is classically considered an intracellular chaperone with residence in the mitochondria; nonetheless, in the last few years it has been found extracellularly as well as in the cell membrane. Important questions remain pertaining to extracellular Hsp60 such as how generalized is its occurrence outside cells, what are its extracellular functions and the translocation mechanisms that transport the chaperone outside of the cell. These questions are particularly relevant for cancer biology since it is believed that extracellular chaperones, like Hsp70, may play an active role in tumor growth and dissemination. Methodology/Principal Findings S…

Cell SurvivalBlotting WesternCellImmunology/Immunomodulationlcsh:MedicineApoptosisBiologyExosomesCell LineAmilorideCell membraneMicroscopy Electron TransmissionCell Line TumorNeoplasmsBiochemistry/Cell Signaling and Trafficking StructuresExtracellularmedicineHumansSecretionlcsh:ScienceMultidisciplinarySettore BIO/16 - Anatomia Umanabeta-Cyclodextrinslcsh:RChaperonin 60MicrovesiclesCell biologyPathology/PathophysiologyHSP60 Mitochondria Chaperonopatiesmedicine.anatomical_structureCell cultureCulture Media ConditionedCancer cellAcetylcholinesteraselcsh:QExtracellular SpaceK562 CellsIntracellularResearch Article
researchProduct

Aging and asthma: pathophysiological mechanisms

2003

Cellular immunityAllergyAgingbusiness.industryImmunologyRespiratory diseaseImmunitySettore MED/10 - Malattie Dell'Apparato Respiratoriomedicine.diseasePathophysiologyAsthmaPathogenesisImmune systemImmunopathologyImmune SystemImmunologymedicineImmunology and AllergyHumansbusinessLungAsthmaHuman
researchProduct

Serotonin Involvement in the Basal Ganglia Pathophysiology: Could the 5-HT2C Receptor be a New Target for Therapeutic Strategies?.

2006

The basal ganglia are a highly interconnected group of subcortical nuclei in the vertebrate brain that play a critical role not only in the control of movements but also in some cognitive and behavioral functions. Several recent studies have emphasized that serotonergic pathways in the central nervous system (CNS) are intimately involved in the modulation of the basal ganglia and in the pathophysiology of human involuntary movement disorders. These observations are supported by anatomical evidence demonstrating large serotonergic innervation of the basal ganglia. In fact, serotonergic terminals have been reported to make synaptic contacts with dopamine (DA)-containing neurons and gamma-amin…

Central Nervous SystemSerotoninmedicine.medical_specialtySubstantia nigraBiologyIndirect pathway of movementSerotonergicBiochemistrySerotonin AgentsBasal Ganglia DiseasesDopamineInternal medicineSerotonin AgentsDrug DiscoveryBasal gangliaReceptor Serotonin 5-HT2CmedicineAnimalsHumansBasal ganglia diseasegamma-Aminobutyric AcidNeuronsPharmacologyMovement DisordersOrganic ChemistryParkinson Diseasemedicine.diseasebasal ganglion pathophysiology Basal Ganglia Diseases pathophysiologyGlobus pallidusEndocrinologynervous systemSynapsesMolecular Medicinemedicine.drug
researchProduct

The place of Ruscus extract, hesperidin methyl chalcone, and vitamin C in the management of chronic venous disease.

2017

Despite continuous improvement in our knowledge and management of chronic venous disease (CVD), certain areas, such as the role of muscarinic receptors in the pathology and treatment of CVD, remain unexplored. The symposium "The place of Ruscus extract, hesperidin methyl chalcone, and vitamin C in the management of CVD", held at the Annual Meeting of the European Venous Forum on 7-9 July 2016 in London, presented an update on the pathophysiology of CVD and highlighted how the combination of Ruscus extract, hesperidin methyl chalcone, and vitamin C (Ruscus/HMC/VitC; Cyclo 3® Fort), may counteract the deleterious processes underlying CVD. The data presented during this symposium are reported …

ChalconeInflammationAscorbic Acid030204 cardiovascular system & hematologyPharmacologyVeins03 medical and health scienceschemistry.chemical_compoundHesperidin0302 clinical medicineChalconesLondonMedicineHumansVascular DiseasesRandomized Controlled Trials as TopicbiologyVitamin Cbusiness.industryPlant ExtractsHesperidinCongresses as Topicbiology.organism_classificationResponse to treatmentPathophysiologyRuscusTreatment OutcomechemistryRuscus030220 oncology & carcinogenesisChronic DiseaseDrug Therapy Combinationmedicine.symptomCardiology and Cardiovascular MedicineVenous diseasebusinessPhytotherapyInternational angiology : a journal of the International Union of Angiology
researchProduct

Pathophysiology of Solid Tumors

2009

It is generally accepted that tumor blood flow, microcirculation, oxygen and nutrient supply, tissue pH distribution, lactate levels, and the bioenergetic status— factors that are usually closely linked and that define the so-called pathophysiological microenvironment (“tumor pathophysiome”)—can markedly influence the therapeutic response of malignant tumors to conventional irradiation, chemotherapy, other non-surgical treatment modalities, malignant progression, and the cell proliferation activity within tumors. Currently available information on the parameters defining the pathophysiological micromilieu in human tumors is presented in this chapter. According to these data, significant var…

ChemotherapyTumor hypoxiaCell growthbusiness.industrymedicine.medical_treatmentCancer researchmedicineMalignant progressionTumor responsebusinessGrading (tumors)PathophysiologyMicrocirculation
researchProduct

Correlation between Regional Atp and Blood Flow in Tumors and Surrounding Normal Tissue

1994

Various experimental and human tumors are characterized by a marked heterogeneity in the pathophysiologic micromilieu (1, 2). An inadequate and heterogeneous nutritional blood supply has been suggested to explain the non-uniform distribution of oxygen, pH, and high energy phosphates as it has been observed by many investigators (3, 4). Although there is a distinct understanding of the general interrelationships between these parameters (5), little is known about their actual regional correlation, which cannot be assessed by global measurements. With the autoradiographic method for measurement of blood flow (6, 7) and the metabolic imaging with ATP-induced bioluminescence (8, 9) it has becom…

CorrelationHigh-energy phosphatePathologymedicine.medical_specialtyMelanomamedicineNormal tissueDistribution (pharmacology)HamsterBlood flowBiologymedicine.diseasePathophysiology
researchProduct

Sepsis and Coronavirus Disease 2019: Common Features and Anti-Inflammatory Therapeutic Approaches

2020

Great efforts are being made worldwide to identify the specific clinical characteristics of infected critically ill patients that mediate the associated pathogenesis, including vascular dysfunction, thrombosis, dysregulated inflammation, and respiratory complications. Recently, coronavirus disease 2019 has been closely related to sepsis, which suggests that most deaths in ICUs in infected patients are produced by viral sepsis. Understanding the physiopathology of the disease that lead to sepsis after severe acute respiratory syndrome coronavirus 2 infection is a current clinical need to improve intensive care-applied therapies applied to critically ill patients. Although the whole represent…

Critical CareAnti-Inflammatory AgentsInflammationDiseaseCritical Care and Intensive Care MedicinesepsisSepsisPathogenesis03 medical and health sciences0302 clinical medicineImmune systemCoagulopathymedicineHumansanti-inflammatory therapyGlucocorticoidsRespiratory Distress SyndromeSARS-CoV-2business.industryCOVID-19Thrombosis030208 emergency & critical care medicineBlood Coagulation Disordersmedicine.diseaseThrombosisPathophysiologyViewpoints030228 respiratory systemcytokine stormImmunologyCytokinesmedicine.symptombusinesssevere acute respiratory syndrome coronavirus 2Critical Care Medicine
researchProduct

Pacing ventricolare destro: una risorsa o una minaccia?

2005

Early after the beginning of the pacemaker era, endocardial right ventricular apex has been the most extensively used site for cardiac pacing because it was easily accessible and reliable in a long-term perspective. However many data have demonstrated that this kind of pacing is suboptimal from a physiologic point of view because it causes several adverse effects such as altered ventricular contraction geometry, mitral regurgitation, perfusion alterations and interference with myocardial ion channels which determine a worsening of left ventricular function. Several strategies have been proposed to solve these problems (alternative pacing sites, specific algorithms able to reduce the percent…

DDD pacingVVI pacingCardiac pacingPathophysiologyMitral regurgitation
researchProduct

Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals?

2014

A large variability in occurrence, complications, and age/gender manifestations characterizes individual susceptibility of sporadic thoracic aortic aneurysms (TAA), even in subjects with the same risk factor profiles. The reasons are poorly understood. On the other hand, TAA pathophysiology mechanisms remain unclear than those involved in abdominal aorta aneurysms. However, recent evidence is suggesting a crucial role of biological ageing in inter-individual risk variation of cardiovascular diseases, including sporadic TAA. Biological age rather than chronological age is a better predictor of vascular risk. Relevant assumptions support this concept. In confirming this evidence and our preli…

DNA ReplicationMaleTelomerasePathologymedicine.medical_specialtyAgingGenotypeEnzyme-Linked Immunosorbent AssayBiologyPolymerase Chain ReactionArticleAortic aneurysmRisk FactorsGenotypemedicineIn Situ Nick-End LabelingLeukocytesSporadic TAA. Biological ageing . Leukocyte telomere length attrition . Telomere activity alteration . Predictor TAAbiomarkersSettore MED/05 - Patologia ClinicaHumansGenetic Predisposition to DiseaseRisk factorTelomere ShorteningSettore MED/04 - Patologia GeneraleAortic Aneurysm ThoracicSettore MED/23 - Chirurgia CardiacaGeneral MedicineDNAMiddle AgedTelomeremedicine.diseaseMolecular medicineImmunohistochemistryPathophysiologyTelomereAgeingImmunologyFemaleGeriatrics and GerontologyBiomarkersAge (Dordrecht, Netherlands)
researchProduct